Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-12-20
1995-09-26
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, 544268, C07D47306, A61K 3152
Patent
active
054534267
ABSTRACT:
The present invention provides sulfur-containing xanthine derivatives which are 1,3-disubstituted with a C.sub.1 -C.sub.12 alkyl, which may be further substituted with a hydroxy, amino, or halo group, and are 8-substituted with either a cycloalkyl, furyl, thienyl, or substituted phenyl group. These derivatives possess increased selectivity or potency at adenosine receptors.
REFERENCES:
patent: 4546182 (1985-10-01), Kjellin et al.
patent: 4564182 (1985-10-01), Kjellin et al.
patent: 4820709 (1989-04-01), Hofer
patent: 4879296 (1989-11-01), Daluge
patent: 4925847 (1990-05-01), Hofer
Chemical Abstracts vol. 111:77745(g) 1989.
Chemical Abstracts vol. 98 1252(z) (1983).
Chemical Abstracts vol. 98 125211z (1983).
Chemical Abstracts vol. 106 67009K (1987).
Daly John W.
Jacobson Kenneth A.
Neumeyer John L.
Pfleidover Wolfgang
Rizzo Nicholas
The United States of America as represented by the Department of
LandOfFree
Sulfur-containing xanthine derivatives as adenosine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfur-containing xanthine derivatives as adenosine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfur-containing xanthine derivatives as adenosine antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1551975